Join the 200th Anniversary Celebration

Original Article

A New Arenavirus in a Cluster of Fatal Transplant-Associated Diseases

Gustavo Palacios, Ph.D., Julian Druce, Ph.D., Lei Du, Ph.D., Thomas Tran, Ph.D., Chris Birch, Ph.D., Thomas Briese, Ph.D., Sean Conlan, Ph.D., Phenix-Lan Quan, Ph.D., Jeffrey Hui, B.Sc., John Marshall, Ph.D., Jan Fredrik Simons, Ph.D., Michael Egholm, Ph.D., Christopher D. Paddock, M.D., M.P.H.T.M., Wun-Ju Shieh, M.D., Ph.D., M.P.H., Cynthia S. Goldsmith, M.G.S., Sherif R. Zaki, M.D., Ph.D., Mike Catton, M.D., and W. Ian Lipkin, M.D.

N Engl J Med 2008; 358:991-998March 6, 2008

Abstract

Background

Three patients who received visceral-organ transplants from a single donor on the same day died of a febrile illness 4 to 6 weeks after transplantation. Culture, polymerase-chain-reaction (PCR) and serologic assays, and oligonucleotide microarray analysis for a wide range of infectious agents were not informative.

Methods

We evaluated RNA obtained from the liver and kidney transplant recipients. Unbiased high-throughput sequencing was used to identify microbial sequences not found by means of other methods. The specificity of sequences for a new candidate pathogen was confirmed by means of culture and by means of PCR, immunohistochemical, and serologic analyses.

Results

High-throughput sequencing yielded 103,632 sequences, of which 14 represented an Old World arenavirus. Additional sequence analysis showed that this new arenavirus was related to lymphocytic choriomeningitis viruses. Specific PCR assays based on a unique sequence confirmed the presence of the virus in the kidneys, liver, blood, and cerebrospinal fluid of the recipients. Immunohistochemical analysis revealed arenavirus antigen in the liver and kidney transplants in the recipients. IgM and IgG antiviral antibodies were detected in the serum of the donor. Seroconversion was evident in serum specimens obtained from one recipient at two time points.

Conclusions

Unbiased high-throughput sequencing is a powerful tool for the discovery of pathogens. The use of this method during an outbreak of disease facilitated the identification of a new arenavirus transmitted through solid-organ transplantation.

Media in This Article

Figure 1High-Throughput Sequencing Method.
Figure 2Propagation of the New Arenavirus in Tissue Culture.
Article

Methods of cloning nucleic acids of microbial agents directly from clinical specimens offer new opportunities for the surveillance and discovery of pathogens. Molecular techniques have been used successfully in the identification of infectious agents such as the Borna disease virus, hepatitis C virus, Sin Nombre virus, human herpesviruses 6 and 8, Bartonella henselae, Tropheryma whipplei, West Nile virus, and the coronavirus associated with severe acute respiratory syndrome.1

The arenaviruses are enveloped, negative-strand RNA viruses in rodents; these viruses are most frequently transmitted to humans through exposure to infected urine. Infection with the prototype virus, lymphocytic choriomeningitis virus (LCMV), is typically asymptomatic or associated with mild, transient illness; however, LCMV has also been implicated in aseptic meningitis.2 Human-to-human transmission of LCMV during pregnancy has been reported, and infection during the gestational period can result in fetal death, neurologic sequelae, and chorioretinopathy.3 Fatal outbreaks of disease associated with human-to-human transmission of LCMV in recipients of solid-organ transplants have also been described.4 We report the use of unbiased DNA sequencing in the discovery of a new LCMV-related arenavirus that caused fatal disease in three recipients of organs from a single donor.

Methods

Patients and Clinical Course

Three women in Australia who were 63 years of age (Recipient 1), 64 years of age (Recipient 2), and 44 years of age (Recipient 3) received a liver transplant (Recipient 2) or kidney transplants (Recipients 1 and 3) from one male donor who was 57 years of age. The donor died of cerebral hemorrhage 10 days after returning to Australia from a 3-month visit to the former Yugoslavia, where he had traveled in rural areas. The immediate post-transplantation course in the three transplant recipients was unremarkable; however, febrile illnesses with varying degrees of encephalopathy developed in all three, and they died 4 to 6 weeks after transplantation (Table 1Table 1Characteristics of the Organ-Transplant Recipients.). Bacterial and viral cultures; polymerase-chain-reaction (PCR) assays for herpesviruses 1 through 8, lyssavirus, influenza A and B viruses, respiratory syncytial virus, picornavirus, adenovirus, human parainfluenza virus, flavivirus, alphavirus, hantavirus, polyomavirus, Crimean–Congo hemorrhagic fever virus, Rift Valley fever virus, toxoplasma, Mycobacterium tuberculosis, and Mycoplasma pneumoniae; and viral and panmicrobial oligonucleotide microarray analysis4 revealed no candidate pathogens.

Unbiased High-Throughput Sequencing

RNA was extracted from the brain, cerebrospinal fluid, serum, kidney, and liver of Recipient 1, who had received a kidney transplant, and from the cerebrospinal fluid and serum of Recipient 2, who had received a liver transplant. As shown in Figure 1Figure 1High-Throughput Sequencing Method., after digestion with DNase I to eliminate human chromosomal DNA, RNA preparations were amplified by means of reverse-transcriptase PCR (RT-PCR) with the use of random primers.5,6 Amplification products were pooled and sequenced with the use of the GSL FLX platform (454 Life Sciences), but DNA fragmentation was omitted.7 After trimming to remove sequences derived from the amplification primer and after filtration to eliminate highly repetitive sequences, the data set was analyzed by subtracting fragments that matched human sequences, clustering nonredundant sequences,8 and assembling them into contiguous sequences9 for direct comparison with the GenBank databases of nucleic acids and proteins with the use of BLASTN and BLASTX software.10 We analyzed the resulting alignments and assigned them to nodes in the National Center for Biotechnology Information taxonomy database, using a custom software application written in Perl (BioPerl, version 5.8.5).

PCR Quantitation of the Arenavirus Burden

RNA obtained from tissues, plasma, serum, and cerebrospinal fluid was reverse transcribed with the use of random hexamers. PCR was performed with the use of a SYBR Green assay (Applied Biosystems). The following cycling conditions were used: 50°C for 2 minutes and 95°C for 10 minutes, followed by 45 cycles at 95°C for 15 seconds and 60°C for 1 minute. Real-time PCR assays were performed with the following primer set: 5′AGTGCYTGCACAACATCGTTT3′ (forward) and 5′CAATGCCCAGCYTGACAAT3′ (reverse). Thermal cycling was performed with the use of an ABI 7500 real-time PCR system (Applied Biosystems).

Viral Isolation and Analyses

Kidney tissue from Recipient 1 was homogenized in phosphate-buffered saline, centrifuged to pellet cellular debris, filtered, and used to inoculate Vero E6 cells. The cells were monitored daily by means of light microscopy for cytopathic effect and by means of RT-PCR for the presence of arenavirus nucleic acid in supernatant. Monolayers of cells showing cytopathic effects that were also positive for arenavirus nucleic acid were fixed with buffered 4% paraformaldehyde for indirect immunofluorescence and immunohistochemical microscopy and with buffered 2.5% glutaraldehyde for thin-section electron microscopy. Rabbit polyclonal antiserum against Old World arenaviruses, including LCMV, was used as the source of primary antibodies for immunohistochemical analysis. Secondary antibodies were alkaline phosphatase–conjugated goat antibodies against rabbit IgG.4 Immunohistochemical assays were also performed with the use of formalin-fixed, paraffin-embedded tissue sections obtained from the liver and kidney of Recipient 1.

Virus-infected and noninfected (control) Vero E6 cells were fixed with methanol. Serum specimens from the donor, from the recipients, and from 100 randomly chosen control recipients of solid-organ transplants were applied to the fixed cells followed by fluorescein-labeled antihuman IgG or IgM secondary antibodies.

Complete Genome Sequencing and Phylogenetic Analyses

RNA extracted from the liver in Recipient 1 was used as a template to clone and sequence the L and S segments of the virus. The gene fragments obtained by means of pyrosequencing were used to design specific PCR primers; thereafter, consensus primers were designed on the basis of alignments of other arenavirus sequences with the use of the SCPrimer program.11

The L and S segments were assembled and sequenced as a series of overlapping genetic fragments. Evolutionary distances between the assembled segments were computed with the use of the Poisson correction method and expressed in units of amino acid substitutions per site in relation to arenavirus L, glycoprotein precursor, and nucleoprotein amino acid segments in the GenBank database with the use of the MEGA program.12 The percentage of replicate trees in which taxa clustered together in the bootstrap test (1000 replicates) is shown next to the branches. All positions containing alignment gaps and missing data were eliminated only in pairwise sequence comparisons (see Fig. 1a, 1b, and 1c of the Supplementary Appendix, available with the full text of this article at www.nejm.org). The nucleotide and amino acid homologies of each of the arenavirus genes (Z, L, GPC, and NP) to LCMV (the closest completely sequenced relative) are shown in Table 2Table 2Nucleotide and Amino Acid Homologies of the New Arenavirus to Other Arenaviruses.. The sequences are deposited in GenBank (accession numbers EU136038 and EU136039).

Results

RNA from Recipient 2, who had received a liver, and Recipient 1, who had received a kidney, was pooled and amplified for unbiased high-throughput sequencing,7 yielding 103,632 sequence fragments. The sequences recovered ranged in size from 45 to 337 nucleotides, with a mean length of 162. Sequences derived from the amplification primer and highly repetitive sequences were eliminated, yielding a net of 94,043 sequences. These sequences were processed with the use of algorithms that subtract vertebrate sequences, assemble contiguous sequences, and compare the residual nucleotide and deduced amino acid sequences in all six potential open reading frames with motifs represented in databases of microbes.

At the nucleotide level, sequence data were uninformative; however, BLASTX analysis of the deduced protein sequence revealed 14 fragments that were consistent with Old World arenaviruses (12 S-segment and 2 L-segment fragments) sharing the closest relationship to LCMV.

Primers were designed for RT-PCR experiments to detect viral RNA in clinical specimens, assess the similarity of viral sequences among individual organs and recipients, and extend the viral sequence needed to facilitate characterization. Viral RNA was present in a total of 22 of 30 specimens of tissue, blood, or cerebrospinal fluid from all three transplant recipients (Table 3Table 3Viral RNA and Antibody Titers in the Donor and Recipients.). The sequence was identical in all specimens, a finding that was consistent with the introduction of a single virus into all the recipients.

Fresh-frozen kidney tissue from Recipient 1 was homogenized and used to inoculate cultures of Vero E6 cells. A cytopathic effect was observed only in the first passages; thereafter, morphologic characteristics did not differ between infected and control cells. Indirect immunofluorescence assays with the use of polyclonal antibodies against arenaviruses and LCMV showed cytoplasmic distribution of viral antigen. Immunostaining of viral antigens was also seen in infected cells by means of an indirect immunoalkaline phosphatase technique (Figure 2AFigure 2Propagation of the New Arenavirus in Tissue Culture.). Quantitative RT-PCR assays showed increasing concentrations of viral nucleic acid with serial passage. Examination of infected Vero E6 cells by means of thin-section electron microscopy revealed extracellular particles with morphologic features that are characteristic of arenaviruses (Figure 2B).

Immunofluorescence assays for serum antibodies that are reactive with infected Vero E6 cells revealed virus-specific IgM and IgG antibodies in the donor that were consistent with acute infection. Plasma and serum specimens from Recipient 2 that had been collected at two time points 19 days apart (11 days and 30 days after transplantation) were available for analysis. Virus-specific IgG and IgM antibodies were detectable only at the second time point, consistent with seroconversion.

Immunohistochemical analysis of specimens of the liver (Figure 3AFigure 3Predominantly Membranous Distribution of Arenavirus Antigen.) and kidney (Figure 3B) obtained from Recipient 1 showed focal immunostaining of arenavirus antigens. PCR surveys of 100 archived serum or plasma specimens from solid-organ transplant recipients who were not linked to the cluster and who had undergone transplantation in the same city and during the same time period revealed no evidence of infection with this pathogen.

The 3301-nucleotide S-segment and 7215-nucleotide L-segment sequences were cloned from the kidney of Recipient 1 by means of PCR and sequenced. Phylogenetic characterization was limited by the paucity of available sequences deposited in public databases; nonetheless, L- and S-segment analyses were consistent with the presence of a new arenavirus. Whereas sequences in the nucleoprotein and glycoprotein genes on the S segment were closest to the LCMV strain LE13 and M1 and M2 isolates14 (Table 2, and Fig. 1b and 1c of the Supplementary Appendix), the L-segment sequence indicated a closer relationship to Kodoko virus. Strain LE was isolated in France from an infected fetus. M1 and M2 were isolated in Japan from wild mice. Kodoko virus was recently isolated in Africa from wild mice (Fig. 1a of the Supplementary Appendix).15 Reassortment is well described in arenaviruses and could account for differences in phylogenetic relationships based on L- and S-segment sequences. However, reassortment cannot be implicated without a complete genomic sequence for the viruses used in these phylogenetic analyses.

Discussion

Two clusters of transmission of arenavirus through solid-organ transplantation have been reported.4 In each cluster, recipients linked to a single donor died of an unexplained infectious disease 9 to 76 days after transplantation. In neither cluster did the donor have a history of acute infectious disease or evidence of infection by PCR or serologic analysis; however, in one cluster, a pet hamster that had recently been introduced into the donor's household was found to be infected with the same virus that was detected in the recipients. LCMV was implicated after the results of viral culture and electron microscopy triggered specific immunohistochemical and molecular tests for arenaviruses.

In our cluster, a new arenavirus was first detected through unbiased high-throughput sequencing. Thereafter, the infection was confirmed by means of culture, electron microscopy, and specific immunohistochemical and serologic tests. As in the other two reported clusters of transplant-associated transmission, we detected no viral nucleic acids in the donor and found no history of acute infectious disease; however, the presence of IgG and IgM antibodies confirmed recent infection. We were also unable to obtain any information indicating that the donor had been exposed to rodents; however, his history of recent travel suggests that he may have been infected before returning to Australia from southern Europe, where such exposure may have occurred in a rural area.

Although we have not fulfilled Koch's postulates, evidence implicating this new virus in the outbreak of infection among patients who received transplants is compelling. All three recipients received organs from the same donor and died within days of one another after febrile illness. Identical viral sequences were obtained from all the recipients. The virus is new and was not detected in 100 organ recipients who were not linked to this cluster. The results of serologic analysis of specimens obtained from the donor were consistent with recent infection, and seroconversion was observed in one recipient.

Unbiased high-throughput sequencing has been used to characterize complex mixtures of microflora in environmental contexts16; we have shown that this strategy can be used to address a suspected outbreak of infectious disease. Its use in the context of investigating a cluster of cases of acute disease associated with organ transplantation facilitated the rapid implication of a new arenavirus not detected by other methods. This technique may prove useful as a new tool in the identification and surveillance of pathogens in chronic as well as acute disease.

Supported by grants from the National Institutes of Health (U54AI57158, to the Northeast Biodefense Center–Lipkin; U01AI070411; AI062705; and HL083850).

Drs. Du, Simons, and Egholm report being employees of 454 Life Sciences. Dr. Lipkin reports being a member of the scientific advisory board of 454 Life Sciences during a portion of the time the work reported here was pursued. Drs. Du, Simons, Egholm, and Lipkin report holding stock options in 454 Life Sciences before it was purchased by Roche Diagnostics in May 2007. No other potential conflict of interest relevant to this article was reported.

Drs. Palacios and Druce contributed equally to this article.

This article (10.1056/NEJMoa073785) was published at www.nejm.org on February 6, 2008.

We thank David Riches for skillful technical assistance.

Source Information

From the Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York (G.P., T.B., S.C., P.-L.Q., J.H., W.I.L.); Victorian Infectious Diseases Reference Laboratory, Victoria, Australia (J.D., T.T., C.B., J.M., M.C.); 454 Life Sciences, Branford, CT (L.D., J.F.S., M.E.); and the Centers for Disease Control and Prevention, Atlanta (C.D.P., W.-J.S., C.S.G., S.R.Z.).

Address reprint requests to Dr. Lipkin at the Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 W. 168th St., New York, NY 10032, or at , or to Dr. Catton at the Victorian Infectious Diseases Reference Laboratory, Locked Bag 815, Carlton South, Victoria 3053, Australia, or at .

References

References

  1. 1

    Lipkin WI, Briese T. Emerging tools for microbial diagnosis, surveillance and discovery. In: Lemon SM, Hamburg MA, Sparling PF, Choffnes ER, Mack A, eds. Global infectious disease surveillance and detection: assessing the challenges — finding solutions: workshop summary. Washington, DC: Institute of Medicine, 2007:177.

  2. 2

    Buchmeier M, de la Torre J-C, Peters CJ. Arenaviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2007:1791-828.

  3. 3

    Jamieson DJ, Kourtis AP, Bell M, Rasmussen SA. Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol 2006;194:1532-1536
    CrossRef | Web of Science | Medline

  4. 4

    Fischer SA, Graham MB, Kuehnert MJ, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006;354:2235-2249
    Full Text | Web of Science | Medline

  5. 5

    Palacios G, Quan PL, Jabado OJ, et al. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis 2007;13:73-81
    CrossRef | Web of Science | Medline

  6. 6

    Bohlander SK, Espinosa R III, Le Beau MM, Rowley JD, Diaz MO. A method for the rapid sequence-independent amplification of microdissected chromosomal material. Genomics 1992;13:1322-1324
    CrossRef | Web of Science | Medline

  7. 7

    Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005;437:376-380
    Web of Science | Medline

  8. 8

    Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 2006;22:1658-1659
    CrossRef | Web of Science | Medline

  9. 9

    Huang X, Madan A. CAP3: a DNA sequence assembly program. Genome Res 1999;9:868-877
    CrossRef | Web of Science | Medline

  10. 10

    Altschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402
    CrossRef | Web of Science | Medline

  11. 11

    Jabado OJ, Palacios G, Kapoor V, et al. Greene SCPrimer: a rapid comprehensive tool for designing degenerate primers from multiple sequence alignments. Nucleic Acids Res 2006;34:6605-6611
    CrossRef | Web of Science | Medline

  12. 12

    Kumar S, Tamura K, Nei M. MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004;5:150-163
    CrossRef | Web of Science | Medline

  13. 13

    Meritet JF, Lewin F, Krivine A, et al. Human fetal lymphocytic choriomeningitis virus infection with a new genomic variant. Bethesda, MD: National Center for Biotechnology Information, 2006. (Accessed February 11, 2008, at http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucc&id=120971516.)

  14. 14

    Ike F, Bourgade F, Ohsawa K, et al. Lymphocytic choriomeningitis infection undetected by dirty-bedding sentinel monitoring and revealed after embryo transfer of an inbred strain derived from wild mice. Comp Med 2007;57:272-281
    Web of Science | Medline

  15. 15

    Lecompte E, ter Meulen J, Emonet S, Daffis S, Charrel RN. Genetic identification of Kodoko virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa. Virology 2007;364:178-183
    CrossRef | Web of Science | Medline

  16. 16

    Venter JC, Remington K, Heidelberg JF, et al. Environmental genome shotgun sequencing of the Sargasso Sea. Science 2004;304:66-74
    CrossRef | Web of Science | Medline

Citing Articles (112)

Citing Articles

  1. 1

    Natalia Rego, Sergio Bianchi, Pilar Moreno, Helena Persson, Anders Kvist, Alvaro Pena, Pablo Oppezzo, Hugo Naya, Carlos Rovira, Guillermo Dighiero, Otto Pritsch. (2012) Search for an aetiological virus candidate in chronic lymphocytic leukaemia by extensive transcriptome analysis. British Journal of Haematologyn/a-n/a
    CrossRef

  2. 2

    Kristine M. Wylie, George M. Weinstock, Gregory A. Storch. (2012) Emerging view of the human virome. Translational Research
    CrossRef

  3. 3

    Christopher D. Sibley, Gisele Peirano, Deirdre L. Church. (2012) Molecular methods for pathogen and microbial community detection and characterization: Current and potential application in diagnostic microbiology. Infection, Genetics and Evolution 12:3, 505-521
    CrossRef

  4. 4

    Amy C. Shurtleff, Steven B. Bradfute, Sheli R. Radoshitzky, Peter B. Jahrling, Jens H. Kuhn, Sina Bavari. 2012. Arenaviruses: Hemorrhagic Fevers. , 211-235.
    CrossRef

  5. 5

    Jay A. Fishman, Linda Scobie, Yasuhiro Takeuchi. (2012) Xenotransplantation-associated infectious risk: a WHO consultation. Xenotransplantation 19:2, 72-81
    CrossRef

  6. 6

    A. V. Bussetti, G. Palacios, A. Travassos da Rosa, N. Savji, K. Jain, H. Guzman, S. Hutchison, V. L. Popov, R. B. Tesh, W. I. Lipkin. (2012) Genomic and antigenic characterization of Jos virus. Journal of General Virology 93:2, 293-298
    CrossRef

  7. 7

    David C. Henderson, John Hammond. (2012) CKC: Isolation of Nucleic Acids from a Diversity of Plants Using CTAB and Silica Columns. Molecular Biotechnology
    CrossRef

  8. 8

    John L Mokili, Forest Rohwer, Bas E Dutilh. (2012) Metagenomics and future perspectives in virus discovery. Current Opinion in Virology
    CrossRef

  9. 9

    Vladimir Lazarevic, Katrine Whiteson, Nadia Gaia, Yann Gizard, David Hernandez, Laurent Farinelli, Magne Osteras, Patrice Francois, Jacques Schrenzel. (2012) Analysis of the salivary microbiome using culture-independent techniques. Journal of Clinical Bioinformatics 2:1, 4
    CrossRef

  10. 10

    Sebastian B. Lucas, Sherif R. Zaki, Bernard C. Portmann. 2012. Other viral and infectious diseases and HIV-related liver disease. , 403-466.
    CrossRef

  11. 11

    Mei-Ning Xing, Xue-Zhu Zhang, He Huang. (2012) Application of metagenomic techniques in mining enzymes from microbial communities for biofuel synthesis. Biotechnology Advances
    CrossRef

  12. 12

    Judith M. Fontana, Elizabeth Alexander, Mirella Salvatore. (2012) Translational research in infectious disease: current paradigms and challenges ahead. Translational Research
    CrossRef

  13. 13

    Tina Ganzenmueller, Yuri Yakushko, Jeanette Kluba, Cornelia Henke-Gendo, Ralf Gutzmer, Thomas F. Schulz. (2012) Next generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma. International Journal of Cancern/a-n/a
    CrossRef

  14. 14

    S. Igonet, M.-C. Vaney, C. Vonhrein, G. Bricogne, E. A. Stura, H. Hengartner, B. Eschli, F. A. Rey. (2011) X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proceedings of the National Academy of Sciences 108:50, 19967-19972
    CrossRef

  15. 15

    Johanna Ekström, Davit Bzhalava, Daniel Svenback, Ola Forslund, Joakim Dillner. (2011) High throughput sequencing reveals diversity of Human Papillomaviruses in cutaneous lesions. International Journal of Cancer 129:11, 2643-2650
    CrossRef

  16. 16

    Juan C. Zapata, C. David Pauza, Mahmoud M. Djavani, Juan D. Rodas, Dmitry Moshkoff, Joseph Bryant, Eugene Ateh, Cybele Garcia, Igor S. Lukashevich, Maria S. Salvato. (2011) Lymphocytic choriomeningitis virus (LCMV) infection of macaques: A model for Lassa fever. Antiviral Research 92:2, 125-138
    CrossRef

  17. 17

    Niko Beerenwinkel, Osvaldo Zagordi. (2011) Ultra-deep sequencing for the analysis of viral populations. Current Opinion in Virology 1:5, 413-418
    CrossRef

  18. 18

    Theresa R. Harring, Christine A. O’Mahony, John A. Goss. (2011) Extended Donors in Liver Transplantation. Clinics in Liver Disease 15:4, 879-900
    CrossRef

  19. 19

    G. Palacios, J. F. X. Wellehan, S. Raverty, A. V. Bussetti, J. Hui, N. Savji, H. H. Nollens, D. Lambourn, C. Celone, S. Hutchison, C. H. Calisher, O. Nielsen, W. I. Lipkin. (2011) Discovery of an orthoreovirus in the aborted fetus of a Steller sea lion (Eumetopias jubatus). Journal of General Virology 92:11, 2558-2565
    CrossRef

  20. 20

    Nicholas Bexfield, Paul Kellam. (2011) Metagenomics and the molecular identification of novel viruses. The Veterinary Journal 190:2, 191-198
    CrossRef

  21. 21

    Samuel Cordey, Roland Sahli, Marie-Laurence Moraz, Christine Estrade, Laurence Morandi, Pascal Cherpillod, Remi N. Charrel, Stefan Kunz, Laurent Kaiser. (2011) Analytical validation of a lymphocytic choriomeningitis virus real-time RT-PCR assay. Journal of Virological Methods 177:1, 118-122
    CrossRef

  22. 22

    Takaaki Nakaya, Shota Nakamura, Yoshiko Okamoto, Yoshiyuki Nagai, Jun Kawai, Yoshihide Hayashizaki, Tetsuya Iida, Toshihiro Horii. 2011. Direct Metagenomic Detection of Viral Pathogens in Human Specimens Using an Unbiased High-Throughput Sequencing Approach. , 73-80.
    CrossRef

  23. 23

    Ian P. Adams, Rachel H. Glover, Wendy A. Monger, Richard Thwaites, Rick Mumford, Elena Jackeviciene, Meletele Navalinskiene, Marija Samuitiene, Neil Boonham. 2011. Next-Generation Sequencing and Metagenomic Analysis: A Universal Diagnostic Tool in Plant Pathology. , 63-72.
    CrossRef

  24. 24

    Shannon J. Williamson. 2011. Viral Metagenomics. , 3-13.
    CrossRef

  25. 25

    David J. Studholme, Rachel H. Glover, Neil Boonham. (2011) Application of High-Throughput DNA Sequencing in Phytopathology. Annual Review of Phytopathology 49:1, 87-105
    CrossRef

  26. 26

    Chintamani Atreya, Hira Nakhasi, Paul Mied, Jay Epstein, James Hughes, Marta Gwinn, Steven Kleinman, Roger Dodd, Susan Stramer, Mark Walderhaug, Peter Ganz, Raymond Goodrich, Clark Tibbetts, David Asher. (2011) FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion 51:8, 1855-1871
    CrossRef

  27. 27

    Feero, W. Gregory, Guttmacher, Alan E., , Relman, David A., . (2011) Microbial Genomics and Infectious Diseases. New England Journal of Medicine 365:4, 347-357
    Full Text

  28. 28

    R.C. Novais, Y.R. Thorstenson. (2011) The evolution of Pyrosequencing® for microbiology: From genes to genomes. Journal of Microbiological Methods 86:1, 1-7
    CrossRef

  29. 29

    N. Savji, G. Palacios, A. Travassos da Rosa, S. Hutchison, C. Celone, J. Hui, T. Briese, C. H. Calisher, R. B. Tesh, W. I. Lipkin. (2011) Genomic and phylogenetic characterization of Leanyer virus, a novel orthobunyavirus isolated in northern Australia. Journal of General Virology 92:7, 1676-1687
    CrossRef

  30. 30

    G. Palacios, A. Travassos da Rosa, N. Savji, W. Sze, I. Wick, H. Guzman, S. Hutchison, R. Tesh, W. I. Lipkin. (2011) Aguacate virus, a new antigenic complex of the genus Phlebovirus (family Bunyaviridae). Journal of General Virology 92:6, 1445-1453
    CrossRef

  31. 31

    M. G. Ison, M. A. Nalesnik. (2011) An Update on Donor-Derived Disease Transmission in Organ Transplantation. American Journal of Transplantation 11:6, 1123-1130
    CrossRef

  32. 32

    Gregory I. Snell, Glen P. Westall. (2011) Selection and Management of the Lung Donor. Clinics in Chest Medicine 32:2, 223-232
    CrossRef

  33. 33

    M. G. Ison, E. Llata, C. S. Conover, J. J. Friedewald, S. I. Gerber, A. Grigoryan, W. Heneine, J. M. Millis, D. M. Simon, C.-G. Teo, M. J. Kuehnert, . (2011) Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ Donor to Four Transplant Recipients. American Journal of Transplantation 11:6, 1218-1225
    CrossRef

  34. 34

    Heidi H. Kong. (2011) Skin microbiome: genomics-based insights into the diversity and role of skin microbes. Trends in Molecular Medicine 17:6, 320-328
    CrossRef

  35. 35

    Aleksandar D Kostic, Akinyemi I Ojesina, Chandra Sekhar Pedamallu, Joonil Jung, Roel G W Verhaak, Gad Getz, Matthew Meyerson. (2011) PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nature Biotechnology 29:5, 393-396
    CrossRef

  36. 36

    R.N. Charrel, B. Coutard, C. Baronti, B. Canard, A. Nougairede, A. Frangeul, B. Morin, S. Jamal, C.L. Schmidt, R. Hilgenfeld, B. Klempa, X. de Lamballerie. (2011) Arenaviruses and hantaviruses: From epidemiology and genomics to antivirals. Antiviral Research 90:2, 102-114
    CrossRef

  37. 37

    Nicolas J Mueller, Yasuhiro Takeuchi, Giada Mattiuzzo, Linda Scobie. (2011) Microbial safety in xenotransplantation. Current Opinion in Organ Transplantation 16:2, 201-206
    CrossRef

  38. 38

    Sebastien E. Emonet, Shuzo Urata, Juan C. de la Torre. (2011) Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology 411:2, 416-425
    CrossRef

  39. 39

    Andrew M. Lee, Antonella Pasquato, Stefan Kunz. (2011) Novel approaches in anti-arenaviral drug development. Virology 411:2, 163-169
    CrossRef

  40. 40

    A.B. Allison, G. Palacios, A. Travassos da Rosa, V.L. Popov, L. Lu, S.Y. Xiao, K. DeToy, T. Briese, W.I. Lipkin, M.K. Keel, D.E. Stallknecht, G.R. Bishop, R.B. Tesh. (2011) Characterization of Durham virus, a novel rhabdovirus that encodes both a C and SH protein. Virus Research 155:1, 112-122
    CrossRef

  41. 41

    Evan Skowronskia, W. Ian Lipkinb. 2011. Molecular Microbial Surveillance and Discovery in Bioforensics. , 173-185.
    CrossRef

  42. 42

    Lin-Fa Wang. (2011) Discovering novel zoonotic viruses. New South Wales Public Health Bulletin 22:6, 113
    CrossRef

  43. 43

    Marie-Laurence Moraz, Stefan Kunz. (2011) Pathogenesis of arenavirus hemorrhagic fevers. Expert Review of Anti-infective Therapy 9:1, 49-59
    CrossRef

  44. 44

    Robert C. Huang, Jay A. Fishman. (2011) Screening of Deceased Organ Donors: No Easy Answers. Transplantation 91:2, 146-149
    CrossRef

  45. 45

    Christian Gabriel, Stephanie Stabentheiner, Martin Danzer, Johannes Pröll. (2011) What Next? The Next Transit from Biology to Diagnostics: Next Generation Sequencing for Immunogenetics. Transfusion Medicine and Hemotherapy 38:5, 308-317
    CrossRef

  46. 46

    Cybele C García, Claudia S Sepúlveda, Elsa B Damonte. (2011) Novel therapeutic targets for arenavirus hemorrhagic fevers. Future Virology 6:1, 27-44
    CrossRef

  47. 47

    Steven Kleinman, Claire Cameron, Brian Custer, Michael Busch, Louis Katz, Boris Kralj, Ian Matheson, Ken Murphy, Jutta Preiksaitis, Dana Devine. (2010) Modeling the risk of an emerging pathogen entering the Canadian blood supply. Transfusion 50:12, 2592-2606
    CrossRef

  48. 48

    Sandeep J. Joseph, Timothy D. Read. (2010) Bacterial population genomics and infectious disease diagnostics. Trends in Biotechnology 28:12, 611-618
    CrossRef

  49. 49

    Wei Wang, Philippe Cavailler, Peijun Ren, Jing Zhang, Wei Dong, Huajie Yan, Sek Mardy, Johann Cailhol, Philippe Buchy, Jun Sheng, Arnaud Fontanet, Vincent Deubel. (2010) Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai. Journal of Clinical Virology 49:3, 211-218
    CrossRef

  50. 50

    S. Emonet, H. N. Shah, A. Cherkaoui, J. Schrenzel. (2010) Application and use of various mass spectrometry methods in clinical microbiology. Clinical Microbiology and Infection 16:11, 1604-1613
    CrossRef

  51. 51

    Stéphane Bretagne. (2010) Advances and Prospects for Molecular Diagnostics of Fungal Infections. Current Infectious Disease Reports 12:6, 430-436
    CrossRef

  52. 52

    K. Araki, S. Gangappa, D. L. Dillehay, B. T. Rouse, C. P. Larsen, R. Ahmed. (2010) Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. Journal of Experimental Medicine 207:11, 2355-2367
    CrossRef

  53. 53

    Mark J Pallen, Nicholas J Loman, Charles W Penn. (2010) High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. Current Opinion in Microbiology 13:5, 625-631
    CrossRef

  54. 54

    Shawn P.E. Nishi, Vincent G. Valentine, Steve Duncan. (2010) Emerging Bacterial, Fungal, and Viral Respiratory Infections in Transplantation. Infectious Disease Clinics of North America 24:3, 541-555
    CrossRef

  55. 55

    David R. Murdoch, Lance C. Jennings, Niranjan Bhat, Trevor P. Anderson. (2010) Emerging Advances in Rapid Diagnostics of Respiratory Infections. Infectious Disease Clinics of North America 24:3, 791-807
    CrossRef

  56. 56

    Walid Mohamed El Moghazy, Yasuhiro Ogura, Minata Mutsuko, Kouji Harada, Akio Koizumi, Shinji Uemoto. (2010) Pediatric living-donor liver transplantation for acute liver failure: analysis of 57 cases. Transplant International 23:8, 823-830
    CrossRef

  57. 57

    Jay A. Fishman, Nicolas C. Issa. (2010) Infection in Organ Transplantation: Risk Factors and Evolving Patterns of Infection. Infectious Disease Clinics of North America 24:2, 273-283
    CrossRef

  58. 58

    Michele I. Morris, Staci A. Fischer, Michael G. Ison. (2010) Infections Transmitted by Transplantation. Infectious Disease Clinics of North America 24:2, 497-514
    CrossRef

  59. 59

    G. Palacios, N. Savji, J. Hui, A. Travassos da Rosa, V. Popov, T. Briese, R. Tesh, W. I. Lipkin. (2010) Genomic and phylogenetic characterization of Merino Walk virus, a novel arenavirus isolated in South Africa. Journal of General Virology 91:5, 1315-1324
    CrossRef

  60. 60

    P. A. Revill, D. S. Bowden, P. A. White. 2010. Viral Genotyping and the Sequencing Revolution. , 40-58.
    CrossRef

  61. 61

    Steven A Pergam, Keith R Jerome. 2010. Viral Infections of the Immunocompromised Host. , 458-474.
    CrossRef

  62. 62

    Patrick Tang, Charles Chiu. (2010) Metagenomics for the discovery of novel human viruses. Future Microbiology 5:2, 177-189
    CrossRef

  63. 63

    Saša A. Živković, Hoda Abdel-Hamid. (2010) Neurologic Manifestations of Transplant Complications. Neurologic Clinics 28:1, 235-251
    CrossRef

  64. 64

    Phenix-Lan Quan, Sandra Junglen, Alla Tashmukhamedova, Sean Conlan, Stephen K. Hutchison, Andreas Kurth, Heinz Ellerbrok, Michael Egholm, Thomas Briese, Fabian H. Leendertz, W. Ian Lipkin. (2010) Moussa virus: A new member of the Rhabdoviridae family isolated from Culex decens mosquitoes in Côte d’Ivoire. Virus Research 147:1, 17-24
    CrossRef

  65. 65

    Philip M Sherman, Juan C Ossa, Eytan Wine. (2010) Bacterial infections: new and emerging enteric pathogens. Current Opinion in Gastroenterology 26:1, 1-4
    CrossRef

  66. 66

    R.N. Charrel, X. de Lamballerie. (2010) Zoonotic aspects of arenavirus infections. Veterinary Microbiology 140:3-4, 213-220
    CrossRef

  67. 67

    Peter M. Rabinowitz, Lisa A. Conti. 2010. Zoonoses. , 105-298.
    CrossRef

  68. 68

    RIMA F. KHABBAZ, STEPHEN M. OSTROFF, JAMES W. LeDUC, ROBIN MOSELEY, JAMES M. HUGHES. 2010. Emerging and Reemerging Infectious Disease Threats. , 199-219.
    CrossRef

  69. 69

    C.J. PETERS. 2010. Lymphocytic Choriomeningitis Virus, Lassa Virus, and the South American Hemorrhagic Fevers. , 2295-2301.
    CrossRef

  70. 70

    S. A. Fischer, R. K. Avery, . (2009) Screening of Donor and Recipient Prior to Solid Organ Transplantation. American Journal of Transplantation 9, S7-S18
    CrossRef

  71. 71

    P. A. Grossi, J. A. Fishman, . (2009) Donor-Derived Infections in Solid Organ Transplant Recipients. American Journal of Transplantation 9, S19-S26
    CrossRef

  72. 72

    Michael G. Ison, Valentina Stosor. (2009) Transplantation of high-risk donor organs: a survey of US solid organ transplant center practices as reported by transplant infectious diseases physicians. Clinical Transplantation 23:6, 866-873
    CrossRef

  73. 73

    Gregory I Snell, Glen P Westall. (2009) Donor selection and management. Current Opinion in Organ Transplantation 14:5, 471-476
    CrossRef

  74. 74

    Stefan Kunz. 2009. Arenaviruses. .
    CrossRef

  75. 75

    Juan C. De La Torre. (2009) Molecular and Cell Biology of the Prototypic Arenavirus LCMV: Implications for Understanding and Combating Hemorrhagic Fever Arenaviruses. Annals of the New York Academy of Sciences 1171, E57-E64
    CrossRef

  76. 76

    Jay A. Fishman, D. Michael Strong, Matthew J. Kuehnert. (2009) Organ and tissue safety workshop 2007: advances and challenges. Cell and Tissue Banking 10:3, 271-280
    CrossRef

  77. 77

    M. G. Ison, J. Hager, E. Blumberg, J. Burdick, K. Carney, J. Cutler, J. M. DiMaio, R. Hasz, M. J. Kuehnert, E. Ortiz-Rios, L. Teperman, M. Nalesnik. (2009) Donor-Derived Disease Transmission Events in the United States: Data Reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. American Journal of Transplantation 9:8, 1929-1935
    CrossRef

  78. 78

    Tracy Tucker, Marco Marra, Jan M. Friedman. (2009) Massively Parallel Sequencing: The Next Big Thing in Genetic Medicine. The American Journal of Human Genetics 85:2, 142-154
    CrossRef

  79. 79

    Michael G. Ison. (2009) The Epidemiology and Prevention of Donor-Derived Infections. Advances in Chronic Kidney Disease 16:4, 234-241
    CrossRef

  80. 80

    IAN P. ADAMS, RACHEL H. GLOVER, WENDY A. MONGER, RICK MUMFORD, ELENA JACKEVICIENE, MELETELE NAVALINSKIENE, MARIJA SAMUITIENE, NEIL BOONHAM. (2009) Next-generation sequencing and metagenomic analysis: a universal diagnostic tool in plant virology. Molecular Plant Pathology 10:4, 537-545
    CrossRef

  81. 81

    J. F. Meritet, A. Krivine, F. Lewin, M. H. Poissonnier, R. Poizat, P. Loget, F. Rozenberg, P. Lebon. (2009) A case of congenital lymphocytic choriomeningitis virus (LCMV) infection revealed by hydrops fetalis. Prenatal Diagnosis 29:6, 626-627
    CrossRef

  82. 82

    Stefan Kunz. (2009) Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus–host interaction. Virology 387:2, 245-249
    CrossRef

  83. 83

    M. Al Rwahnih, S. Daubert, D. Golino, A. Rowhani. (2009) Deep sequencing analysis of RNAs from a grapevine showing Syrah decline symptoms reveals a multiple virus infection that includes a novel virus. Virology 387:2, 395-401
    CrossRef

  84. 84

    Linda Scobie, Yasuhiro Takeuchi. (2009) Porcine endogenous retrovirus and other viruses in xenotransplantation. Current Opinion in Organ Transplantation 14:2, 175-179
    CrossRef

  85. 85

    Mariachiara Tallacchini, Sadek Beloucif. (2009) Regulatory issues in xenotransplantation: recent developments. Current Opinion in Organ Transplantation 14:2, 180-185
    CrossRef

  86. 86

    Antonis Rokas, Patrick Abbot. (2009) Harnessing genomics for evolutionary insights. Trends in Ecology & Evolution 24:4, 192-200
    CrossRef

  87. 87

    Christine Uhlenhaut, Jeffrey I. Cohen, Daniel Fedorko, Santosh Nanda, Philip R. Krause. (2009) Use of a universal virus detection assay to identify human metapneumovirus in a hematopoietic stem cell transplant recipient with pneumonia of unknown origin. Journal of Clinical Virology 44:4, 337-339
    CrossRef

  88. 88

    S. F. Emonet, L. Garidou, D. B. McGavern, J. C. de la Torre. (2009) Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proceedings of the National Academy of Sciences 106:9, 3473-3478
    CrossRef

  89. 89

    Bridget S. Banach, Jan M. Orenstein, Linda M. Fox, Scott H. Randell, Anne H. Rowley, Susan C. Baker. (2009) Human airway epithelial cell culture to identify new respiratory viruses: Coronavirus NL63 as a model. Journal of Virological Methods 156:1-2, 19-26
    CrossRef

  90. 90

    Chau-Ting Yeh. (2009) Is the NV-F agent a novel hepatitis virus?. Future Microbiology 4:2, 123-125
    CrossRef

  91. 91

    Kenneth L Tyler. (2009) Neurological infections: advances in therapy, outcome, and prediction. The Lancet Neurology 8:1, 19-21
    CrossRef

  92. 92

    M.G. Bissell. (2009) A New Arenavirus in a Cluster of Fatal Transplant-Associated Diseases. Yearbook of Pathology and Laboratory Medicine 2009, 254-255
    CrossRef

  93. 93

    T.L. Pruett. (2009) A New Arenavirus in a Cluster of Fatal Transplant-Associated Diseases. Yearbook of Surgery 2009, 88-89
    CrossRef

  94. 94

    A. Kapoor, J. Victoria, P. Simmonds, E. Slikas, T. Chieochansin, A. Naeem, S. Shaukat, S. Sharif, M. M. Alam, M. Angez, C. Wang, R. W. Shafer, S. Zaidi, E. Delwart. (2008) A highly prevalent and genetically diversified Picornaviridae genus in South Asian children. Proceedings of the National Academy of Sciences 105:51, 20482-20487
    CrossRef

  95. 95

    Althea A. Capul, Juan Carlos de la Torre. (2008) A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding. Virology 382:1, 107-114
    CrossRef

  96. 96

    Agustín E. Ure, P. Daniel Ghiringhelli, Robert D. Possee, Shigeru Morikawa, Víctor Romanowski. (2008) Argentine hemorrhagic fever diagnostic test based on recombinant Junín virus N protein. Journal of Medical Virology 80:12, 2127-2133
    CrossRef

  97. 97

    Shimon Kusne. (2008) Regarding unexpected severe and life-threatening donor-transmitted viral infections and use of high-risk behavior donors. Liver Transplantation 14:11, 1564-1568
    CrossRef

  98. 98

    Staci A. Fischer. (2008) Emerging Viruses in Transplantation: There Is More to Infection After Transplant Than CMV and EBV. Transplantation 86:10, 1327-1339
    CrossRef

  99. 99

    Jonathan M Rothberg, John H Leamon. (2008) The development and impact of 454 sequencing. Nature Biotechnology 26:10, 1117-1124
    CrossRef

  100. 100

    Costi D. Sifri, Ann Karen C. Brassinga, Tanya Flohr, Jason M. Kinchen, Kevin C. Hazen, Robert G. Sawyer, Timothy L. Pruett, Hugo Bonatti. (2008) Moraxella osloensis bacteremia in a kidney transplant recipient. Transplant International 21:10, 1011-1013
    CrossRef

  101. 101

    Avak Kahvejian, John Quackenbush, John F Thompson. (2008) What would you do if you could sequence everything?. Nature Biotechnology 26:10, 1125-1133
    CrossRef

  102. 102

    Philip Hunter. (2008) Viral vigilance. New surveillance strategies and methods help to identify dangerous pathogens earlier: a prerequisite for efficient countermeasures. EMBO reports 9:10, 948-950
    CrossRef

  103. 103

    Christopher D. Hillyer, Neil Blumberg, Simone A. Glynn, Paul M. Ness, . (2008) Transfusion recipient epidemiology and outcomes research: possibilities for the future. Transfusion 48:8, 1530-1537
    CrossRef

  104. 104

    Andrew L. Mason, Karen Doucette, Gane Ka-Shu Wong, Kris Kowdley, Geoffrey McCaughan, Christian Trautwein. (2008) Metagenomics and the case of the deadly hamster. Hepatology 48:2, 679-683
    CrossRef

  105. 105

    Robert A. Dunstan, Clive R. Seed, Anthony J. Keller. (2008) Emerging viral threats to the Australian blood supply. Australian and New Zealand Journal of Public Health 32:4, 354-360
    CrossRef

  106. 106

    Rémi N Charrel, Xavier de Lamballerie, Sébastien Emonet. (2008) Phylogeny of the genus Arenavirus. Current Opinion in Microbiology 11:4, 362-368
    CrossRef

  107. 107

    Phenix-Lan Quan, Thomas Briese, Gustavo Palacios, W. Ian Lipkin. (2008) Rapid sequence-based diagnosis of viral infection. Antiviral Research 79:1, 1-5
    CrossRef

  108. 108

    (2008) A New Arenavirus in Transplantation. New England Journal of Medicine 358:24, 2638-2639
    Full Text

  109. 109

    A. Humar, J. A. Fishman. (2008) Donor-Derived Infection: Old Problem, New Solutions?. American Journal of Transplantation 8:6, 1087-1088
    CrossRef

  110. 110

    Laura MacConaill, Matthew Meyerson. (2008) Adding pathogens by genomic subtraction. Nature Genetics 40:4, 380-382
    CrossRef

  111. 111

    Whitley, Richard, . (2008) The New Age of Molecular Diagnostics for Microbial Agents. New England Journal of Medicine 358:10, 988-989
    Full Text

  112. 112

    David M. Miller, Thomas B. Thornley, Dale L. Greiner, Aldo A. Rossini. (2008) Viral Infection: A Potent Barrier to Transplantation Tolerance. Clinical and Developmental Immunology 2008, 1-14
    CrossRef

Letters